Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
Blasco-Benito S, Moreno E, Seijo-Vila M, Tundidor I, Andradas C, Caffarel MM, Caro-Villalobos M, Urigüen L, Diez-Alarcia R, Moreno-Bueno G, Hernández L, Manso L, Homar-Ruano P, McCormick PJ, Bibic L, Bernadó-Morales C, Arribas J, Canals M, Casadó V, Canela EI, Guzmán M, Pérez-Gómez E, Sánchez C. Blasco-Benito S, et al. Among authors: guzman m. Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3863-3872. doi: 10.1073/pnas.1815034116. Epub 2019 Feb 7. Proc Natl Acad Sci U S A. 2019. PMID: 30733293 Free PMC article.
Cannabinoids and cell fate.
Guzmán M, Sánchez C, Galve-Roperh I. Guzmán M, et al. Pharmacol Ther. 2002 Aug;95(2):175-84. doi: 10.1016/s0163-7258(02)00256-5. Pharmacol Ther. 2002. PMID: 12182964 Review.
Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Guzmán M. Velasco G, et al. Among authors: guzman m. Neuropharmacology. 2004 Sep;47(3):315-23. doi: 10.1016/j.neuropharm.2004.04.016. Neuropharmacology. 2004. PMID: 15275820 Review.
Cannabinoids and ceramide: two lipids acting hand-by-hand.
Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Haro A, Guzmán M. Velasco G, et al. Among authors: guzman m. Life Sci. 2005 Aug 19;77(14):1723-31. doi: 10.1016/j.lfs.2005.05.015. Life Sci. 2005. PMID: 15958274 Review.
Cannabinoids and gliomas.
Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M. Velasco G, et al. Among authors: guzman m. Mol Neurobiol. 2007 Aug;36(1):60-7. doi: 10.1007/s12035-007-0002-5. Epub 2007 Jun 28. Mol Neurobiol. 2007. PMID: 17952650 Review.
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.
Caffarel MM, Andradas C, Mira E, Pérez-Gómez E, Cerutti C, Moreno-Bueno G, Flores JM, García-Real I, Palacios J, Mañes S, Guzmán M, Sánchez C. Caffarel MM, et al. Among authors: guzman m. Mol Cancer. 2010 Jul 22;9:196. doi: 10.1186/1476-4598-9-196. Mol Cancer. 2010. PMID: 20649976 Free PMC article.
Towards the use of cannabinoids as antitumour agents.
Velasco G, Sánchez C, Guzmán M. Velasco G, et al. Among authors: guzman m. Nat Rev Cancer. 2012 May 4;12(6):436-44. doi: 10.1038/nrc3247. Nat Rev Cancer. 2012. PMID: 22555283 Review.
Cannabinoids: a new hope for breast cancer therapy?
Caffarel MM, Andradas C, Pérez-Gómez E, Guzmán M, Sánchez C. Caffarel MM, et al. Among authors: guzman m. Cancer Treat Rev. 2012 Nov;38(7):911-8. doi: 10.1016/j.ctrv.2012.06.005. Epub 2012 Jul 7. Cancer Treat Rev. 2012. PMID: 22776349 Review.
1,514 results